本頁面由Tiger Trade Technology Pte. Ltd.提供服務

無限製藥

0.0160
-0.0008-4.76%
成交量:114.18萬
成交額:1.72萬
市值:145.22萬
市盈率:-0.03
高:0.0190
開:0.0160
低:0.0115
收:0.0168
52周最高:30.05
52周最低:0.0111
股本:9,076.11萬
流通股本:8,190.54萬
量比:1.30
換手率:1.39%
股息:- -
股息率:- -
每股收益(TTM):-0.4604
每股收益(LYR):-9.5156
淨資產收益率:-3521.35%
總資產收益率:-60.70%
市淨率:-0.04
市盈率(LYR):0.00

資料載入中...

2022/02/10

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/18

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/01/05

重要事件披露

8-K - Current report
2021/12/10

重要事件披露

8-K - Current report
2021/09/10

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/10

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/09/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/09/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

持股變動聲明

3 - Initial statement of beneficial ownership of securities
2021/08/03

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/02

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/27

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/27

重要事件披露

8-K - Current report
2021/06/17

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/06/11

重要事件披露

8-K - Current report
2021/06/11

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/05/19

SEC問詢函

CORRESP [Cover] - Correspondence
2021/05/13

重要事件披露

8-K - Current report
2021/05/13

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/03/16

重要事件披露

8-K - Current report